Neuronetics to Report First Quarter 2023 Financial and Operating Results and Host Conference Call
MALVERN, Pa., April 25, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it plans to release first quarter 2023 financial and operating results prior to market open on Tuesday, May 9th, 2023. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day.
Related news for (STIM)
- Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
- Neuronetics Reports First Quarter 2025 Financial and Operating Results
- Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/04/25 01:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/04/25 12:00 PM